STOCK TITAN

Kaya Hldgs Stock Price, News & Analysis

KAYS OTC Link

Company Description

Kaya Holdings, Inc. (OTCQB: KAYS) is a fully reporting, US-based publicly traded company that describes itself as a "mind care" company. According to its public disclosures, Kaya Holdings has operations in the emerging psilocybin treatment sector and in medical/recreational cannabis, and is developing activities related to digital assets and cryptocurrency through a new subsidiary and a proposed Digital Assets Treasury (DAT) strategy.

Business Focus and Operating Segments

Kaya Holdings states that it has operations in the psilocybin treatment sector through its majority owned subsidiary Fifth Dimension Therapeutics, Inc. (FDT). FDT serves as the company’s operating branch in the psychedelic treatment sector, including operation of mushroom cultivation facilities and The Sacred Mushroom™ psilocybin treatment centers. The company reports that The Sacred Mushroom is a licensed psilocybin treatment center in Portland, Oregon, authorized by the Oregon Health Authority to administer psilocybin treatments within the state regulatory framework.

In addition to psychedelics, Kaya Holdings reports historical and ongoing involvement in medical and recreational cannabis. The company states that in 2014 it became the first US public company to own and operate a medical cannabis dispensary in Portland, Oregon, under the Kaya Shack™ brand. It further discloses interests in three cannabis licenses, with one license in Portland, Oregon, and two in Greece, and references cannabis-related activities through subsidiaries such as Marijuana Holdings Americas, Inc., Kaya Brands International, Inc., and Kaya Brands USA, Inc.

The Sacred Mushroom™ Psilocybin Treatment Center

Through FDT, Kaya Holdings operates The Sacred Mushroom psilocybin treatment center in Portland, Oregon. The company’s news releases describe The Sacred Mushroom as a legally licensed psilocybin treatment center authorized by the Oregon Health Authority to administer psilocybin treatments. The facility is described as occupying approximately 11,000 square feet on the top floor of a historic building in downtown Portland, offering private treatment rooms, group session areas, an indoor garden, and activity zones for yoga, listening stations, journaling, art expression, and other journey-enhancing activities.

The company highlights a proprietary experience framework called "Synergy by Design", which is presented as allowing guests to customize aspects of their psilocybin sessions, including space, sound, scent, and activities such as creative expression and mind-body practices. Kaya Holdings’ disclosures emphasize that The Sacred Mushroom is intended to provide a curated setting for psilocybin experiences in accordance with Oregon’s psilocybin regulations.

Cannabis Operations and International Footprint

Kaya Holdings reports that it continues to be involved in cannabis through several subsidiaries. Marijuana Holdings Americas, Inc. is described as owning the Kaya Shack brand of licensed medical and recreational marijuana stores and the Kaya Farms™ brand of cannabis production and processing operations in the United States. Kaya Brands International, Inc. is presented as the vehicle for non-U.S. operations, including cultivation activities under development in Greece and Israel. Kaya Brands USA, Inc. is reported to own proprietary brands of cannabis extracts, oils, pre-rolls, topicals, edibles and beverages, cannaceuticals and related accessories.

The company’s disclosures indicate that it has interests in three cannabis licenses, one in Portland, Oregon, and two in Greece, and that it has sought to shift portions of its cannabis operations to serve the European Union through its international subsidiaries.

Digital Assets and Cryptocurrency Strategy

In more recent communications, Kaya Holdings has described plans to develop a cryptocurrency operating subsidiary and pursue a Digital Assets Treasury (DAT) strategy. The company has announced that it engaged Greentree Financial Group, Inc. and Conduit Advisors, LLC to assist with the development of this subsidiary and related cryptocurrency operations. According to its press releases and related Form 8-K filings, Kaya Holdings and its advisors are reviewing potential plans to enter the cryptocurrency industry, including possibilities such as licensed cryptocurrency custody and trading services in the United States, Grand Cayman and other jurisdictions, and collaborations with cryptocurrency foundations, for-profit companies and Decentralized Autonomous Organizations.

The company has also stated that it is exploring a joint venture with one or more cryptocurrencies, with a focus on candidates among the top cryptocurrencies by market capitalization and potential alignment with networks such as Solana, Ethereum or Polygon. Kaya Holdings presents the DAT concept as a way to hold yield-generating digital assets on its balance sheet and has indicated that it views its public company status as a potential platform for implementing this strategy.

Capital Structure and Change in Control

According to a Form 8-K filed in October 2025, Kaya Holdings entered into debt reduction and debt conversion agreements with various debt holders, converting a substantial portion of its outstanding debt into equity. The filing reports that the company issued shares of common stock in satisfaction of debt obligations, including a significant issuance to CVC International Ltd., which has been described as a principal source of capital for the company since 2014. As a result of these conversions, the filing states that CVC now holds a majority of the voting power of the company’s capital stock, and that a change in control of the company is deemed to have taken place.

Regulatory Status and Reporting

Kaya Holdings identifies itself as a fully reporting company under the US securities laws, with its common stock listed for trading on the OTCQB market under the symbol KAYS. The company files periodic and current reports with the US Securities and Exchange Commission, including Forms 10-Q, 10-K, and 8-K. A Form 12b-25 notification of late filing indicates that the company has, at times, required additional time to complete financial statements and file quarterly reports, while stating its intention to file within the permitted extension period.

In its public communications, Kaya Holdings repeatedly notes that its business plans in psychedelics and cannabis are subject to state and local laws and to federal enforcement policies and priorities. The company cautions that advice of counsel, potential federal, state or local legal actions, and changes in government policy or law may affect its operations and shareholder value. It also notes that certain initiatives, such as the launch and expansion of The Sacred Mushroom psilocybin treatment center and the implementation of its digital assets strategy, are dependent on factors such as licensing, financing, capital structure adjustments and other conditions.

Summary

Overall, Kaya Holdings, Inc. presents itself as a diversified "mind care" holding company focused on regulated psilocybin treatment services, cannabis-related operations in the United States and abroad, and an emerging strategic focus on digital assets and cryptocurrency through a planned Digital Assets Treasury model. Its activities span licensed psilocybin service delivery in Oregon, branded cannabis retail and production, international cannabis cultivation projects, and exploratory work in digital asset treasuries, all within the framework of US public company reporting and applicable regulatory regimes.

Stock Performance

$—
0.00%
0.00
Last updated:
-7%
Performance 1 year
$831.3K

Financial Highlights

$7K
Revenue (TTM)
-$2.1M
Net Income (TTM)
-$831K
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Kaya Hldgs (KAYS)?

The current stock price of Kaya Hldgs (KAYS) is $0.0372 as of February 26, 2026.

What is the market cap of Kaya Hldgs (KAYS)?

The market cap of Kaya Hldgs (KAYS) is approximately 831.3K. Learn more about what market capitalization means .

What is the revenue (TTM) of Kaya Hldgs (KAYS) stock?

The trailing twelve months (TTM) revenue of Kaya Hldgs (KAYS) is $7K.

What is the net income of Kaya Hldgs (KAYS)?

The trailing twelve months (TTM) net income of Kaya Hldgs (KAYS) is -$2.1M.

What is the earnings per share (EPS) of Kaya Hldgs (KAYS)?

The diluted earnings per share (EPS) of Kaya Hldgs (KAYS) is $-0.07 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Kaya Hldgs (KAYS)?

The operating cash flow of Kaya Hldgs (KAYS) is -$831K. Learn about cash flow.

What is the profit margin of Kaya Hldgs (KAYS)?

The net profit margin of Kaya Hldgs (KAYS) is -29168.2%. Learn about profit margins.

What is the operating margin of Kaya Hldgs (KAYS)?

The operating profit margin of Kaya Hldgs (KAYS) is -28343.5%. Learn about operating margins.

What is the gross margin of Kaya Hldgs (KAYS)?

The gross profit margin of Kaya Hldgs (KAYS) is -5.1%. Learn about gross margins.

What is the current ratio of Kaya Hldgs (KAYS)?

The current ratio of Kaya Hldgs (KAYS) is 0.01, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Kaya Hldgs (KAYS)?

The gross profit of Kaya Hldgs (KAYS) is -$366 on a trailing twelve months (TTM) basis.

What is the operating income of Kaya Hldgs (KAYS)?

The operating income of Kaya Hldgs (KAYS) is -$2.0M. Learn about operating income.

What does Kaya Holdings, Inc. do?

Kaya Holdings, Inc. describes itself as a mind care company with operations in the emerging psilocybin treatment sector and in medical/recreational cannabis. Through subsidiaries, it operates The Sacred Mushroom psilocybin treatment center in Portland, Oregon, holds interests in cannabis licenses in Oregon and Greece, and is developing a digital assets treasury and cryptocurrency-focused subsidiary.

Where does Kaya Holdings trade and under what symbol?

Kaya Holdings, Inc. states that it is a fully reporting, US-based publicly traded company listed for trading on the OTCQB market under the symbol KAYS.

What is The Sacred Mushroom™ and how is it related to Kaya Holdings?

The Sacred Mushroom is a psilocybin treatment center in Portland, Oregon that Kaya Holdings operates through its majority owned subsidiary Fifth Dimension Therapeutics, Inc. The facility is described as a licensed psilocybin service center authorized by the Oregon Health Authority, offering psilocybin treatments in a curated environment with customizable settings and activities.

How is Kaya Holdings involved in the cannabis industry?

Kaya Holdings reports that it has medical and recreational cannabis operations through subsidiaries. It states that it became the first US public company to own and operate a medical cannabis dispensary in Portland, Oregon under the Kaya Shack brand, has interests in three cannabis licenses in Oregon and Greece, and operates cannabis-related brands and cultivation or processing activities through entities such as Marijuana Holdings Americas, Inc., Kaya Brands International, Inc., and Kaya Brands USA, Inc.

What is Kaya Holdings’ Digital Assets Treasury (DAT) strategy?

Kaya Holdings has announced plans to develop a cryptocurrency operating subsidiary and pursue a Digital Assets Treasury strategy. According to its press releases and related SEC filings, the company is working with Greentree Financial Group and Conduit Advisors to explore cryptocurrency-related operations and potential joint ventures with established cryptocurrencies, with the goal of holding yield-generating digital assets on its balance sheet.

What role does Fifth Dimension Therapeutics, Inc. play in Kaya Holdings’ business?

Fifth Dimension Therapeutics, Inc. is described by Kaya Holdings as its operating branch in the psychedelic treatment sector. It is responsible for mushroom cultivation facilities and the operation of The Sacred Mushroom psilocybin treatment centers, and serves as the vehicle for the company’s psilocybin-related activities.

Has Kaya Holdings undergone any recent changes in control?

A Form 8-K filed in October 2025 reports that Kaya Holdings entered into debt reduction and debt conversion agreements that resulted in the issuance of common stock to various debt holders, including CVC International Ltd. The filing states that CVC now holds a majority of the voting power of the company’s capital stock and that a change in control of the company is deemed to have taken place.

How does Kaya Holdings describe the regulatory risks it faces?

In its public communications, Kaya Holdings notes that its plans in psychedelics and cannabis depend on state and local laws and on federal enforcement policies and priorities. It cautions that legal advice, potential government actions, and changes in laws or policies may affect its business operations and shareholder value, and it highlights that certain projects depend on licensing, financing and other conditions.

What geographic markets does Kaya Holdings mention in its disclosures?

Kaya Holdings mentions operations and facilities in Portland, Oregon, and references activities or licenses in Greece and Israel through its subsidiaries. It also notes historical and advisory connections to Grand Cayman in relation to its planned cryptocurrency and digital assets activities.

How does Kaya Holdings communicate with its shareholders and interested parties?

Kaya Holdings’ news releases frequently invite shareholders and other interested parties to contact the company, update their contact information, and request operational updates. The company provides email contact details in those releases and indicates that it responds to inquiries from stockholders and other stakeholders.